DAF-16

DAF-16 is the sole C. elegans member of the FOXO transcription factor family β€” the single ancestral worm gene that mammals have expanded to four paralogs (6). It is the canonical longevity transcription factor of invertebrate aging biology: loss of DAF-16 activity fully suppresses the near-doubling of lifespan seen in daf-2 (IIS receptor) loss-of-function animals 1, and overexpression or nuclear activation of DAF-16 is sufficient to extend lifespan in multiple contexts. The central regulatory logic β€” reduced insulin/IGF signaling β†’ AKT inactivity β†’ nuclear FOXO β†’ longevity gene expression β€” is conserved from worm to mammals (see foxo3).

Identity

  • UniProt: O16850 (DAF16_CAEEL; Swiss-Prot reviewed)
  • NCBI Gene: 172981
  • WormBase: WBGene00000912
  • HGNC: null β€” worm gene; no human HGNC entry
  • GenAge: not independently listed; longevity effects captured via daf-2 (GenAge entry) and the IIS pathway
  • Length: 541 amino acids (canonical isoform per UniProt O16850); at least 8 isoforms produced by alternative splicing per current WormBase/UniProt annotations β€” the founding papers described 3 isoforms: daf-16a1, daf-16a2, and daf-16b (Ogg 1997), plus 2 alternatively spliced forms in the Lin 1997 cDNA analysis (510 aa and 508 aa); the expanded count reflects subsequent WormBase curation. Isoform-specific sequence lengths should be confirmed against current WormBase needs-canonical-id
  • Mammalian orthologs: FOXO1, FOXO3, FOXO4, FOXO6 β€” DAF-16 is the single ancestral FOXO; functionally closest to FOXO3 in the context of longevity regulation 2

Domain organization

DAF-16 shares the canonical FOXO domain architecture:

DomainApproximate residues (canonical isoform)Function
N-terminal disordered region1–174Contains AKT phosphorylation sites (see below); intrinsically disordered
Forkhead DNA-binding domain (FHD)175–268 (UniProt)Sequence-specific binding to DAF-16 binding elements (DBEs); also binds DAE (DAF-16 associated elements)
Nuclear export sequence (NES)C-terminal to FHD14-3-3–mediated cytoplasmic retention when AKT-phosphorylated
C-terminal transactivation domain~400–541Transcriptional activation; isoform variation at C-terminus affects target-gene selectivity

Key phosphorylation sites

AKT-1 and AKT-2 phosphorylate DAF-16 at three conserved sites analogous to the mammalian AKT sites on FOXO3 (Thr32, Ser253, Ser315):

  • Thr273 β€” confirmed phosphothreonine per UniProt O16850; promotes 14-3-3 binding β†’ cytoplasmic sequestration
  • Ser319 β€” phosphorylated by SGK-1 (serum/glucocorticoid kinase ortholog) and CaMK2 ortholog UNC-43 per UniProt
  • Additional AKT-1/AKT-2-dependent sites have been mapped biochemically; full site-by-site epistasis not yet published at atomic resolution needs-replication

JNK-1 (stress-activated kinase) phosphorylates DAF-16 to promote nuclear import under stress conditions β€” an AKT-opposing phosphorylation 2.

Regulation by the IIS pathway

The IGF-1 signaling (IIS) pathway is the primary upstream regulator of DAF-16 nuclear localization:

DAF-2 (insulin/IGF-1 receptor) β†’ AGE-1 (PI3K catalytic subunit)
  β†’ PIP3 β†’ PDK-1 β†’ AKT-1 / AKT-2
  β†’ phospho-DAF-16 β†’ 14-3-3 binding β†’ cytoplasmic retention β†’ INACTIVE

Under low IIS (food scarcity, stress, genetic daf-2 or age-1 LoF):

Low PIP3 β†’ AKT-1/AKT-2 inactive β†’ DAF-16 unphosphorylated
  β†’ nuclear import β†’ target gene transactivation β†’ longevity program

PPTR-1 (PP2A regulatory subunit B56) dephosphorylates AKT-1 to oppose this pathway, providing a second tier of DAF-16 activation 2. needs-replication β€” PPTR-1 mechanism is known from a limited number of studies.

DAF-16 nuclear localization was directly visualized using GFP::DAF-16 reporter strains 3; dynamic translocation from cytoplasm to nucleus in response to reduced IIS is one of the clearest in-vivo demonstrations of kinase-controlled transcription factor localization in any organism. (Note: the full nuclear translocation dynamics upon daf-2 perturbation were characterized in subsequent work β€” Lin et al. 2001, Nat Genet 28:139 β€” not by Lin 1997, which is a cloning paper.) needs-canonical-id

Key genetic interactions

daf-2 (IIS receptor) β€” founding paper

daf-2 loss-of-function (LoF) mutants live ~twice as long as wild-type N2 worms 1. This lifespan extension is completely suppressed by simultaneous daf-16 LoF β€” demonstrating that DAF-16 is the essential effector of daf-2 longevity 1. This result, published in 1993, launched the modern era of longevity genetics.

DimensionStatusNotes
Pathway conserved in humans?yesIIS β†’ AKT β†’ FOXO axis highly conserved; identical phosphorylation sites
Phenotype conserved in humans?partialFOXO3A variants associate with human longevity (see foxo3); no direct equivalent of daf-2 LoF longevity in humans
Replicated in humans?noCannot LoF the insulin/IGF receptor for longevity in humans; observational GWAS data only

needs-human-replication β€” Causal longevity evidence is entirely invertebrate (and some mammalian model-organism); direct evidence in humans is observational only.

sir-2.1 (sirtuin) β€” DAF-16-dependent longevity

Overexpression of sir-2.1 (the C. elegans ortholog of mammalian SIRT1) extends lifespan in a DAF-16-dependent manner: sir-2.1 overexpression no longer extends lifespan when daf-16 is knocked down 4. This established DAF-16 as a critical downstream effector of sirtuin-mediated longevity in worms β€” though later work in flies and mammals complicated the conserved-sirtuin-longevity narrative (see sirt1).

aak-2 (AMPK) β€” parallel pathway, not upstream

aak-2 (AAK-2; C. elegans AMPK Ξ±-subunit) LoF shortens lifespan ~12%; daf-16 LoF shortens lifespan; aak-2;daf-16 double mutants are ~15% shorter-lived than either single mutant 5. This additive shortening in the double mutant demonstrates that AAK-2 and DAF-16 act in parallel, not a linear AAK-2 β†’ DAF-16 hierarchy 5. The AMPK pathway therefore extends lifespan via a DAF-16-independent route in worms β€” a key constraint when extrapolating mammalian AMPK-longevity mechanisms.

hsf-1 (heat-shock factor) β€” partial cooperation

HSF-1 (heat-shock factor 1) and DAF-16 cooperate to promote longevity downstream of daf-2 LoF 6. Simultaneous knockdown of both hsf-1 and daf-16 further shortens daf-2 lifespan beyond either alone, suggesting partially independent transcriptional programs converge on the longevity phenotype 6. no-fulltext-access β€” Hsu 2003 (Science) is closed-access; claims cannot be independently verified from local PDF.

Downstream transcriptional program

A microarray study by Murphy et al. 2003 identified DAF-16 target genes systematically 7. The DAF-16 regulon includes:

  • Stress-resistance genes: sod-3 (MnSOD ortholog), hsp-12.6 (small heat-shock protein), mtl-1 (metallothionein)
  • Antimicrobial genes: lys-7 and multiple lysozyme-family members β€” DAF-16 links longevity to innate immunity
  • Metabolic genes: lipid-binding proteins, fatty acid metabolic enzymes
  • Negative regulators: daf-16 also activates inhibitors of its own pathway (feedback), including pptr-1 (PP2A regulatory subunit)

The DAF-16 regulon is divided into genes that require nuclear DAF-16 for activation (Class I β€” repressed by IIS) and genes that require nuclear DAF-16 for repression (Class II β€” activated by IIS) 7. Both classes contribute to longevity; the Class II set includes several pro-aging genes.

Aging context and model-organism translation

DAF-16 is the entry point for understanding transcriptional control of aging. It demonstrates that:

  1. A single transcription factor can substantially reprogram lifespan β€” DAF-16 nuclear activity increases maximum lifespan nearly twofold in daf-2 LoF animals.
  2. The IIS-FOXO axis is ancient and conserved β€” the same logic (reduced insulin signaling β†’ nuclear FOXO β†’ longevity) operates in flies (dFOXO), mice (Igf1r+/- β†’ FOXO activation; see igf1r), and potentially humans (FOXO3A GWAS β€” see foxo3).
  3. Longevity is transcriptionally programmed, not just passively accumulated damage β€” DAF-16 target genes actively defend against stress and infection, reframing aging as a regulated process 2.

The major limitation is quantitative: daf-2 LoF in a poikilothermic invertebrate with a 3-week lifespan does not translate directly to magnitude of effect in mammals. Mammalian IIS pathway reduction in mice yields modest lifespan extensions ranging from ~15% to 40% across different perturbations (see igf1r), not twofold 2. needs-replication β€” the specific Igf1r+/- female mouse extension figure (~26% in Holzenberger 2003) is not stated explicitly in Kenyon 2010; the review gives a range across multiple mouse models.

Nomenclature note

The gene name daf-16 derives from β€œabnormal DAuer Formation” β€” DAF-16 was originally identified as a regulator of dauer larva entry (the C. elegans hibernation-like state induced by starvation/crowding). The connection between dauer regulation and longevity reflects the conserved logic: IIS low β†’ daf-16 nuclear β†’ dauer/longevity programs. Downstream dauer and longevity targets partially overlap but are not identical. See caenorhabditis-elegans for dauer biology context.

Gaps and limitations

  • needs-human-replication β€” All causal longevity data from C. elegans (and partially from mice/flies); no human LoF equivalent.
  • needs-canonical-id β€” Isoform-specific sequence lengths and phosphosite assignments vary by isoform; canonical isoform boundaries should be confirmed against WormBase.
  • no-fulltext-access β€” Kenyon 1993 (10.1038/366461a0) and Hsu 2003 (10.1126/science.1083701) are closed-access; quantitative claims from those papers cannot be verified against local PDFs.
  • needs-replication β€” Exact phosphosite mapping for all 8 isoforms; PPTR-1 dephosphorylation mechanism; relative contributions of DAF-16 isoforms to different phenotypic outputs.
  • no-mechanism β€” How nuclear DAF-16 distinguishes Class I from Class II target genes at the chromatin level (co-factor specificity not fully characterized).

Pathway membership

  • insulin-igf1 β€” primary regulatory context; DAF-16 is the key transcriptional output
  • ampk β€” parallel longevity pathway (aak-2 acts in parallel, not upstream)
  • deregulated-nutrient-sensing β€” hallmark overlap: DAF-16 is the effector linking reduced nutrient sensing to longevity
  • foxo3 β€” primary mammalian ortholog; human aging-associated GWAS hits
  • daf-2 β€” upstream insulin/IGF receptor; daf-2 LoF is the founding longevity mutation
  • age-1 β€” PI3K ortholog; AGE-1 is the catalytic PI3K downstream of DAF-2
  • sir-2.1 β€” sirtuin whose longevity effect requires DAF-16
  • aak-2 β€” AMPK ortholog; parallel longevity effector
  • caenorhabditis-elegans β€” model organism context; IIS pathway in worm aging
  • insulin-igf1 β€” the pathway DAF-16 gates
  • ampk β€” the parallel pathway
  • akt β€” AKT1/2 human ortholog; phosphorylates FOXO family members in mammals

Footnotes

Footnotes

  1. doi:10.1038/366461a0 Β· Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R Β· in-vivo (C. elegans) Β· daf-2(e1370) LoF ~2Γ— lifespan; completely suppressed by daf-16 LoF Β· model: C. elegans N2 and mutant strains Β· not_oa no-fulltext-access ↩ ↩2 ↩3

  2. doi:10.1038/nature08980 Β· Kenyon CJ Β· review (Nature) Β· comprehensive review of IIS-FOXO axis across species; DAF-16 target genes; mammalian extrapolation; magnitude attenuation Β· local PDF available ↩ ↩2 ↩3 ↩4 ↩5

  3. doi:10.1038/40194 Β· Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G Β· in-vivo (C. elegans) Β· parallel cloning of daf-16 as forkhead TF; identified three alternatively spliced isoforms (daf-16a1, daf-16a2, daf-16b) with distinct forkhead DNA-binding domains; epistasis with daf-2 and age-1; daf-16a::GFP expressed broadly in ectoderm, muscle, intestine, neurons (not pharynx); DAF-16a 65% identical to FKHR and 62% to AFX in forkhead domain Β· model: C. elegans Β· local PDF available ↩

  4. doi:10.1038/35065638 Β· Tissenbaum HA, Guarente L Β· in-vivo (C. elegans) Β· sir-2.1 OE extends lifespan in DAF-16-dependent manner; daf-16 RNAi abolishes sir-2.1 longevity Β· n per strain = 80–451 (per-strain values in paper) Β· model: C. elegans Β· local PDF available ↩

  5. doi:10.1101/gad.1255404 Β· Apfeld J, O’Connor G, McDonagh T, DiStefano PS, Curtis R Β· in-vivo (C. elegans) Β· aak-2 LoF shortens lifespan ~12%; aak-2;daf-16 double mutant ~15% shorter than either single β†’ parallel relationship; aak-2 OE extends lifespan ~13% Β· model: C. elegans Β· local PDF available ↩ ↩2

  6. doi:10.1126/science.1083701 Β· Hsu AL, Murphy CT, Kenyon C Β· in-vivo (C. elegans) Β· HSF-1 and DAF-16 cooperate downstream of daf-2; partial independence of HSF-1 and DAF-16 longevity programs Β· model: C. elegans Β· not_oa no-fulltext-access ↩ ↩2

  7. doi:10.1038/nature01789 Β· Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, Li H, Kenyon C Β· in-vivo / microarray (C. elegans) Β· systematic identification of DAF-16 target genes; Class I (activated) and Class II (repressed) regulon; sod-3, mtl-1, hsp-12.6, lys-7 as representative Class I targets Β· model: C. elegans Β· local PDF available ↩ ↩2